Vol. 5, Issue 11 (2016)
The pharmacologic correction of the immunological state in children with the bronchial asthma
These work devoted to investigation the bronchial asthma in children. The study involved 157 children with asthma in age from 6 to 18 years old. The control group consisted of 20 healthy children of similar age. The study was conducted in two phases. At the first stage we studied the features of the immune status and immunoreactivity. At the second one we explored the possibilities of correction of the detected changes with the different kinds of therapeutic approaches, namely, 49 children received standard therapy, 50 - standard therapy in combination with Beres Drops Plus and 58 children treated with standard therapy, Beres Drops Plus in combination with Likopid. During the treatment and monitoring we can observe the highest positive dynamics in almost all the indicators of phagocytic activity in patients with asthma treated with standard therapy in combination with Beres Drops Plus and Glyukozaminilmuramildipeptid (Likopid).